Preclinical development of an EP2 antagonist for post-seizure cognitive deficits
Nicholas H. Varvel, Radhika Amaradhi, Claudia Espinosa‐García, Steven K. Duddy, Ronald B. Franklin, Avijit Banik, Carlos Alemán-Ruiz, Lisa Blackmer‐Raynolds, Wenyi Wang, Tage Honoré, Thota Ganesh, Raymond Dingledine
Topics & Concepts
NeuroinflammationStatus epilepticusEpilepsyMedicinePharmacologySeizure thresholdAntagonistReceptor antagonistNeurologyDosingCognitive declineInflammationReceptorInternal medicineAnticonvulsantPsychiatryDementiaDiseaseNeuroscience and Neuropharmacology ResearchDrug Transport and Resistance MechanismsReceptor Mechanisms and Signaling